138 related articles for article (PubMed ID: 32164493)
21. [Effect of IV hydration with sodium bicarbonate on high-dose methotrexate disposition kinetics].
Tsuda N; Goto M; Konishi H; Yamashina H
Gan To Kagaku Ryoho; 1984 Apr; 11(4):873-80. PubMed ID: 6326682
[TBL] [Abstract][Full Text] [Related]
22. The Memorial Sloan Kettering Cancer Center experience with outpatient administration of high dose methotrexate with leucovorin rescue.
Zelcer S; Kellick M; Wexler LH; Gorlick R; Meyers PA
Pediatr Blood Cancer; 2008 Jun; 50(6):1176-80. PubMed ID: 18266225
[TBL] [Abstract][Full Text] [Related]
23. The impact of prehydration on the clearance and toxicity of high-dose methotrexate for pediatric patients.
Karremann M; Sauerbier J; Meier C; Vetter C; Schneider H; Buchholz B; Mildenberger S; Dürken M
Leuk Lymphoma; 2014 Dec; 55(12):2874-8. PubMed ID: 24576168
[TBL] [Abstract][Full Text] [Related]
24. High-dose methotrexate in adult oncology patients: a case-control study assessing the risk association between drug interactions and methotrexate toxicity.
Chan AJ; Rajakumar I
J Oncol Pharm Pract; 2014 Apr; 20(2):93-9. PubMed ID: 23698198
[TBL] [Abstract][Full Text] [Related]
25. A single-center qualitative study evaluating the safety and efficacy of a pharmacist-driven protocol for high-dose methotrexate management.
Matta SF; Gieselman LA; Mancini RS
J Oncol Pharm Pract; 2021 Apr; 27(3):588-595. PubMed ID: 32484382
[TBL] [Abstract][Full Text] [Related]
26. Hyper-alkalinization without hyper-hydration for the prevention of high-dose methotrexate acute nephrotoxicity in patients with osteosarcoma.
Mir O; Ropert S; Babinet A; Alexandre J; Larousserie F; Durand JP; Enkaoua E; Anract P; Goldwasser F
Cancer Chemother Pharmacol; 2010 Nov; 66(6):1059-63. PubMed ID: 20155268
[TBL] [Abstract][Full Text] [Related]
27. Toxic epidermal necrolysis following combination of methotrexate and trimethoprim-sulfamethoxazole.
Yang CH; Yang LJ; Jaing TH; Chan HL
Int J Dermatol; 2000 Aug; 39(8):621-3. PubMed ID: 10971734
[TBL] [Abstract][Full Text] [Related]
28. What can clinicians learn from therapeutic studies about the treatment of acute oral methotrexate poisoning?
Chan BS; Dawson AH; Buckley NA
Clin Toxicol (Phila); 2017 Feb; 55(2):88-96. PubMed ID: 28084171
[TBL] [Abstract][Full Text] [Related]
29. Extended duration of prehydration does not prevent nephrotoxicity or delayed drug elimination in high-dose methotrexate infusions: a prospectively randomized cross-over study.
Mikkelsen TS; Mamoudou AD; Tuckuviene R; Wehner PS; Schroeder H
Pediatr Blood Cancer; 2014 Feb; 61(2):297-301. PubMed ID: 24039194
[TBL] [Abstract][Full Text] [Related]
30. Efficacy of urine alkalinization by oral administration of sodium bicarbonate: a prospective open-label trial.
Cohen B; Laish I; Brosh-Nissimov T; Hoffman A; Katz LH; Braunstein R; Sagi R; Michael G
Am J Emerg Med; 2013 Dec; 31(12):1703-6. PubMed ID: 24055481
[TBL] [Abstract][Full Text] [Related]
31. High-dose methotrexate in children with acute lymphoblastic leukemia: 7-hydroxymethotrexate systemic exposure and urinary concentrations at the steady state correlate well with those of methotrexate.
Chládková J; Hak J; Martínková J; Chládek J
Arzneimittelforschung; 2010; 60(12):769-75. PubMed ID: 21265469
[TBL] [Abstract][Full Text] [Related]
32. Effects of sodium in hydration solution on plasma methotrexate concentrations following high-dose methotrexate in children with acute lymphoblastic leukemia.
Kinoshita A; Kurosawa Y; Kondoh K; Suzuki T; Manabe A; Inukai T; Sugita K; Nakazawa S
Cancer Chemother Pharmacol; 2003 Mar; 51(3):256-60. PubMed ID: 12655445
[TBL] [Abstract][Full Text] [Related]
33. Position Paper on urine alkalinization.
Proudfoot AT; Krenzelok EP; Vale JA
J Toxicol Clin Toxicol; 2004; 42(1):1-26. PubMed ID: 15083932
[TBL] [Abstract][Full Text] [Related]
34. Comparison of pharmacokinetics and toxicity after high-dose methotrexate treatments in children with acute lymphoblastic leukemia.
Csordas K; Hegyi M; Eipel OT; Muller J; Erdelyi DJ; Kovacs GT
Anticancer Drugs; 2013 Feb; 24(2):189-97. PubMed ID: 23187460
[TBL] [Abstract][Full Text] [Related]
35. Early recognition of patients with decreased methotrexate clearance following high-dose methotrexate infusion therapy.
Ikeda H; Kihira K; Kuwata N; Arai S; Kimura Y; Miyake K; Kitaura T; Fujimura K; Kuramoto A; Fukuchi H
Hiroshima J Med Sci; 1996 Jun; 45(2):57-62. PubMed ID: 8810132
[TBL] [Abstract][Full Text] [Related]
36. High-dose intravenous methotrexate for patients with nonleukemic leptomeningeal cancer: is intrathecal chemotherapy necessary?
Glantz MJ; Cole BF; Recht L; Akerley W; Mills P; Saris S; Hochberg F; Calabresi P; Egorin MJ
J Clin Oncol; 1998 Apr; 16(4):1561-7. PubMed ID: 9552066
[TBL] [Abstract][Full Text] [Related]
37. Comments on evaluation of an oral sodium bicarbonate protocol for high-dose methotrexate urine alkalinization.
Chyu J; Ali Z; Al-Rahawan MM
Support Care Cancer; 2022 Dec; 30(12):9699-9700. PubMed ID: 36258054
[No Abstract] [Full Text] [Related]
38. Population pharmacokinetics of high-dose methotrexate in Japanese adult patients with malignancies: a concurrent analysis of the serum and urine concentration data.
Fukuhara K; Ikawa K; Morikawa N; Kumagai K
J Clin Pharm Ther; 2008 Dec; 33(6):677-84. PubMed ID: 19138246
[TBL] [Abstract][Full Text] [Related]
39. [Managing methotrexate toxicity: a case report].
Fernández Megía MJ; Alós Almiñana M; Terol Castera MJ
Farm Hosp; 2004; 28(5):371-4. PubMed ID: 15504095
[TBL] [Abstract][Full Text] [Related]
40. Relationship between oral mucositis and high-dose methotrexate therapy in pediatric acute lymphoblastic leukemia.
Maiguma T; Hayashi Y; Ueshima S; Kaji H; Egawa T; Chayama K; Morishima T; Kitamura Y; Sendo T; Gomita Y; Teshima D
Int J Clin Pharmacol Ther; 2008 Nov; 46(11):584-90. PubMed ID: 19000557
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
